This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will provide $608,731 to Brown University to study the impact of Medicare and Medicaid financial policies on post-acute and long-term care utilization and outcomes for persons living with Alzheimer's disease and related dementias (ADRD). The 5-year project aims to leverage Medicare claims and clinical assessment data to examine: 1) changes in nursing home and home health service use by ADRD patients amid...
The National Institute on Aging (NIA) awarded a $1,527,001 Project Grant (CFDA 93.866 - Aging Research) to The RAND Corporation to conduct research on disparities in undiagnosed and misdiagnosed dementia, and the impact on healthcare utilization and costs. The project will develop a novel probabilistic dementia classification method using linked Health and Retirement Study and Medicare data to better estimate the prevalence of Alzheimer's disease and related dementias, especially among...
This Project Grant award of $319,000 from the National Institute on Aging (CFDA 93.866 - Aging Research) to Brown University aims to identify the rate of normative cognitive aging in adults and determine how much faster cognitive aging occurs in individuals with Alzheimer's disease or related dementias. Specifically, the project will use data from the Children of the Depression (CODA) cohort of the Health and Retirement Study to establish a latent variable estimate of general cognitive...
This $680,931 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support a comprehensive research study to address disparities in nursing home care for people with serious mental illness (SMI) and Alzheimer's disease/related dementias (AD/ADRD). The key objectives are to: 1) Assess longitudinal patterns of SMI, AD/ADRD, and comorbid prevalence in nursing homes, including differences by race/ethnicity; 2) Estimate quality of life and quality of care...
The National Institute on Aging (NIA), under the Aging Research (CFDA 93.866) Federal Grant Program, awarded a $199,375 project grant to Brown University. The project aims to examine whether hospices specializing in long-term care (LTC) settings provide better care to beneficiaries with Alzheimer's and related dementias (ADRD) compared to non-LTC hospices. Key objectives include: 1) describing individual, facility, and neighborhood-level characteristics associated with receiving care from LTC...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to examine the use of home-based medical care (HBMC) and telemedicine among persons living with Alzheimer's disease and related dementias (PLWD) in both public (fee-for-service) and private (Medicare Advantage) Medicare plans. The $2,054,062 award will fund a study to identify national trends in HBMC and telemedicine utilization, and rigorously evaluate their impact on outcomes such as treatment...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to evaluate the effects of poverty alleviation policies on the risk and disparities of Alzheimer's disease and related dementias (AD/ADRD). The $131,813 award to Trustees of Boston University, awarded on May 1, 2025, will support a research program with two key objectives: In the K99 phase, the researcher will integrate Health and Retirement Study (HRS) and Medicare data to quantify state-level...
This $4,444,978 federal Project Grant award, issued by the National Institute on Aging (CFDA 93.866 Aging Research program), supports research to characterize cognitive reserve and identify modifiable factors that promote cognitive reserve and resilience to Alzheimer's disease and related dementias (ADRD) among older adults in India, with a focus on those who lack formal education. The project aims to: 1) compare brain pathology measures and their contributions to cognition between older...
This $322,286 federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research to advance health equity in the use of novel treatments for Alzheimer's disease and related dementias (ADRD). The primary objectives are to: Conduct focus groups with diverse individuals affected by ADRD to understand their medication decision-making processes. Design and administer discrete choice experiments to learn how different treatment attributes are...
This $2,365,042 Project Grant was awarded by the National Institute on Aging (NIA) under the Aging Research Federal Grant Program (CFDA 93.866) to conduct research on the biological underpinnings of Alzheimer's disease and related dementias (ADRD). The research aims to better characterize the interplay between biological markers of neurodegeneration, vascular, nutritional, and inflammatory systems, and their interface with social and economic factors, by leveraging cross-national comparisons...